Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edith M Hessel

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
The Journal of Experimental Medicine|June 22, 2005
Nonhuman primate models of asthmaRobert L Coffman, Edith M Hessel
Nature Reviews. Immunology|November 10, 2010
Functions of T cells in asthma: more than just T(H)2 cellsClare M Lloyd, Edith M Hessel
Methods in Molecular Biology (Clifton, N.J.)|April 21, 2009
Biomarkers measuring the activity of Toll-like receptor ligands in clinical development programsPaul Sims, Robert L Coffman, Edith M Hessel
Current Opinion in Pharmacology|June 21, 2015
PI3K inhibitors in inflammation, autoimmunity and cancerAnne-Katrien Stark, Srividya Sriskantharajah, Edith M Hessel, et al.
Pharmaceutical Research|July 13, 2016
Development of a Novel Quantitative Structure-Activity Relationship Model to Accurately Predict Pulmonary Absorption and Replace Routine Use of the Isolated Perfused Respiring Rat Lung ModelChris D Edwards, Chris Luscombe, Peter Eddershaw, et al.
Nature Medicine|May 5, 2007
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonistsHolger Kanzler, Franck J Barrat, Edith M Hessel, et al.
Immunity|March 1, 2002
A restricted subset of dendritic cells captures airborne antigens and remains able to activate specific T cells long after antigen exposureValerie Julia, Edith M Hessel, Laurent Malherbe, et al.
Annals of the New York Academy of Sciences|April 5, 2013
Targeting phosphoinositide 3-kinase δ for the treatment of respiratory diseasesSrividya Sriskantharajah, Nicole Hamblin, Sally Worsley, et al.
Clinical Therapeutics|July 30, 2018
Safety, Tolerability, and Pharmacokinetics of Single and Repeat Doses of Nemiralisib Administered via the Ellipta Dry Powder Inhaler to Healthy SubjectsRobert Wilson, Emily Jarvis, Mickael Montembault, et al.
Clinical and Experimental Pharmacology & Physiology|May 17, 2017
An investigation of the anti-inflammatory effects and a potential biomarker of PI3Kδ inhibition in COPD T cellsAbid Khan, Thomas Southworth, Sally Worsley, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
The Journal of Experimental Medicine|June 22, 2005
Nonhuman primate models of asthmaRobert L Coffman, Edith M Hessel
Nature Reviews. Immunology|November 10, 2010
Functions of T cells in asthma: more than just T(H)2 cellsClare M Lloyd, Edith M Hessel
Methods in Molecular Biology (Clifton, N.J.)|April 21, 2009
Biomarkers measuring the activity of Toll-like receptor ligands in clinical development programsPaul Sims, Robert L Coffman, Edith M Hessel
Current Opinion in Pharmacology|June 21, 2015
PI3K inhibitors in inflammation, autoimmunity and cancerAnne-Katrien Stark, Srividya Sriskantharajah, Edith M Hessel, et al.
Pharmaceutical Research|July 13, 2016
Development of a Novel Quantitative Structure-Activity Relationship Model to Accurately Predict Pulmonary Absorption and Replace Routine Use of the Isolated Perfused Respiring Rat Lung ModelChris D Edwards, Chris Luscombe, Peter Eddershaw, et al.
Nature Medicine|May 5, 2007
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonistsHolger Kanzler, Franck J Barrat, Edith M Hessel, et al.
Immunity|March 1, 2002
A restricted subset of dendritic cells captures airborne antigens and remains able to activate specific T cells long after antigen exposureValerie Julia, Edith M Hessel, Laurent Malherbe, et al.
Annals of the New York Academy of Sciences|April 5, 2013
Targeting phosphoinositide 3-kinase δ for the treatment of respiratory diseasesSrividya Sriskantharajah, Nicole Hamblin, Sally Worsley, et al.
Clinical Therapeutics|July 30, 2018
Safety, Tolerability, and Pharmacokinetics of Single and Repeat Doses of Nemiralisib Administered via the Ellipta Dry Powder Inhaler to Healthy SubjectsRobert Wilson, Emily Jarvis, Mickael Montembault, et al.
Clinical and Experimental Pharmacology & Physiology|May 17, 2017
An investigation of the anti-inflammatory effects and a potential biomarker of PI3Kδ inhibition in COPD T cellsAbid Khan, Thomas Southworth, Sally Worsley, et al.
Pageof 6